Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
Go back to Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1105.28 +3.20 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 255.85 | |||
| Day Low | $1079.22 | EPS | $4.32 | |||
| Volume | 1,646,871 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.76 +0.88 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.88 | 52 Week High | $59.00 | |||
| Open | $46.80 | 52 Week Low | $32.80 | |||
| Day High | $47.12 | P/E | N/A | |||
| Day Low | $46.44 | EPS | $0.00 | |||
| Volume | 14,113,359 | |||||
